Stock Track | Surgery Partners Drops 5.23% Pre-Market on Q1 Earnings Miss and Revenue Shortfall

Stock Track

May 12, 2025

Surgery Partners (SGRY) saw its stock plummet 5.23% in pre-market trading on Monday following the release of its first-quarter 2025 financial results, which fell short of analysts' expectations. The ambulatory surgery center operator reported disappointing earnings and a slight revenue miss, causing concern among investors.

The company announced adjusted earnings per share of $0.04 for Q1, a significant decline from $0.10 in the same period last year and below the FactSet consensus estimate of $0.05. Revenue for the quarter came in at $776 million, narrowly missing the analysts' projection of $777.07 million, despite showing growth from $717.4 million in the previous year.

Despite the earnings setback, Surgery Partners reaffirmed its full-year 2025 revenue guidance of $3.30 billion to $3.45 billion, in line with analysts' expectations of $3.39 billion. However, this reassurance did little to alleviate investor concerns in early trading. The company's ability to meet its annual targets will likely be closely scrutinized in the coming quarters, given the softer-than-expected start to the year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1109586945"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1109586945\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1109586945?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-12 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109586945","market":"hk","top_or_hot":-1,"title":"Stock Track | Surgery Partners Drops 5.23% Pre-Market on Q1 Earnings Miss and Revenue Shortfall","media":"Stock Track","content":"<p>Surgery Partners (SGRY) saw its stock plummet 5.23% in pre-market trading on Monday following the release of its first-quarter 2025 financial results, which fell short of analysts' expectations. The ambulatory surgery center operator reported disappointing earnings and a slight revenue miss, causing concern among investors.</p>\n\n<p>The company announced adjusted earnings per share of $0.04 for Q1, a significant decline from $0.10 in the same period last year and below the FactSet consensus estimate of $0.05. Revenue for the quarter came in at $776 million, narrowly missing the analysts' projection of $777.07 million, despite showing growth from $717.4 million in the previous year.</p>\n\n<p>Despite the earnings setback, Surgery Partners reaffirmed its full-year 2025 revenue guidance of $3.30 billion to $3.45 billion, in line with analysts' expectations of $3.39 billion. However, this reassurance did little to alleviate investor concerns in early trading. The company's ability to meet its annual targets will likely be closely scrutinized in the coming quarters, given the softer-than-expected start to the year.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Surgery Partners Drops 5.23% Pre-Market on Q1 Earnings Miss and Revenue Shortfall</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Surgery Partners Drops 5.23% Pre-Market on Q1 Earnings Miss and Revenue Shortfall\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-12 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Surgery Partners (SGRY) saw its stock plummet 5.23% in pre-market trading on Monday following the release of its first-quarter 2025 financial results, which fell short of analysts' expectations. The ambulatory surgery center operator reported disappointing earnings and a slight revenue miss, causing concern among investors.</p>\n\n<p>The company announced adjusted earnings per share of $0.04 for Q1, a significant decline from $0.10 in the same period last year and below the FactSet consensus estimate of $0.05. Revenue for the quarter came in at $776 million, narrowly missing the analysts' projection of $777.07 million, despite showing growth from $717.4 million in the previous year.</p>\n\n<p>Despite the earnings setback, Surgery Partners reaffirmed its full-year 2025 revenue guidance of $3.30 billion to $3.45 billion, in line with analysts' expectations of $3.39 billion. However, this reassurance did little to alleviate investor concerns in early trading. The company's ability to meet its annual targets will likely be closely scrutinized in the coming quarters, given the softer-than-expected start to the year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SGRY","symbol_name":"Surgery Partners, Inc.","start_time":0,"source_url":"","article_id":"1109586945","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109586945","pubTimestamp":1747051248,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Surgery Partners  saw its stock plummet 5.23% in pre-market trading on Monday following the release of its first-quarter 2025 financial results, which fell short of analysts' expectations. The ambulatory surgery center operator reported disappointing earnings and a slight revenue miss, causing concern among investors.The company announced adjusted earnings per share of $0.04 for Q1, a significant decline from $0.10 in the same period last year and below the FactSet consensus estimate of $0.05. R","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SGRY":"Surgery Partners, Inc."},"translate_title":"由于第一季度盈利未达预期和收入短缺，Surgery Partners盘前下跌5.23%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SGRY":1},"content_text":"Surgery Partners (SGRY) saw its stock plummet 5.23% in pre-market trading on Monday following the release of its first-quarter 2025 financial results, which fell short of analysts' expectations. The ambulatory surgery center operator reported disappointing earnings and a slight revenue miss, causing concern among investors.\nThe company announced adjusted earnings per share of $0.04 for Q1, a significant decline from $0.10 in the same period last year and below the FactSet consensus estimate of $0.05. Revenue for the quarter came in at $776 million, narrowly missing the analysts' projection of $777.07 million, despite showing growth from $717.4 million in the previous year.\nDespite the earnings setback, Surgery Partners reaffirmed its full-year 2025 revenue guidance of $3.30 billion to $3.45 billion, in line with analysts' expectations of $3.39 billion. However, this reassurance did little to alleviate investor concerns in early trading. The company's ability to meet its annual targets will likely be closely scrutinized in the coming quarters, given the softer-than-expected start to the year.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}